March 12, 2014 | Israeli pharmaceutical company Can-Fite Biopharma has raised $5 million in private placement from US investors. The company says it will use the proceeds for further clinical trials of its psoriasis, glaucoma, and liver cancer treatments.
Related posts
Israeli Wave Energy Tech To Create Power In Taiwan
October 08, 2024
Microsoft Creates AI Tool To Help Preserve October 7 Testimonies
October 08, 2024
Water Management Pioneer Unveils Unique New Anti-Leak Platform
October 06, 2024
Israel Sending 20 Green Tech Firms To UN Climate Conference
October 06, 2024
Facebook comments